These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20123826)

  • 1. Nonadherence to medication four years after a first episode of psychosis and associated risk factors.
    Hill M; Crumlish N; Whitty P; Clarke M; Browne S; Kamali M; Kinsella A; Waddington JL; Larkin C; O'Callaghan E
    Psychiatr Serv; 2010 Feb; 61(2):189-92. PubMed ID: 20123826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment and violent behavior in persons with first episode psychosis during a 10-year prospective follow-up study.
    Langeveld J; Bjørkly S; Auestad B; Barder H; Evensen J; Ten Velden Hegelstad W; Joa I; Johannessen JO; Larsen TK; Melle I; Opjordsmoen S; Røssberg JI; Rund BR; Simonsen E; Vaglum P; McGlashan T; Friis S
    Schizophr Res; 2014 Jul; 156(2-3):272-6. PubMed ID: 24837683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication nonadherence and substance abuse in psychotic disorders: impact of depressive symptoms and social stability.
    Elbogen EB; Swanson JW; Swartz MS; Van Dorn R
    J Nerv Ment Dis; 2005 Oct; 193(10):673-9. PubMed ID: 16208163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting relapse after a first episode of non-affective psychosis: a three-year follow-up study.
    Caseiro O; Pérez-Iglesias R; Mata I; Martínez-Garcia O; Pelayo-Terán JM; Tabares-Seisdedos R; Ortiz-García de la Foz V; Vázquez-Barquero JL; Crespo-Facorro B
    J Psychiatr Res; 2012 Aug; 46(8):1099-105. PubMed ID: 22721546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early predictors of nonadherence to antipsychotic therapy in first-episode psychosis.
    Rabinovitch M; Béchard-Evans L; Schmitz N; Joober R; Malla A
    Can J Psychiatry; 2009 Jan; 54(1):28-35. PubMed ID: 19175977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response.
    Lindenmayer JP; Liu-Seifert H; Kulkarni PM; Kinon BJ; Stauffer V; Edwards SE; Chen L; Adams DH; Ascher-Svanum H; Buckley PF; Citrome L; Volavka J
    J Clin Psychiatry; 2009 Jul; 70(7):990-6. PubMed ID: 19497244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cross-sectional observational study of healthcare professional views of factors affecting teenage adherence with antipsychotic medication.
    Ramdour S; Duxbury JA; Becket G; Wilson S
    J Psychiatr Ment Health Nurs; 2015 Sep; 22(7):491-501. PubMed ID: 25990303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for antipsychotic medication non-adherence behaviors and attitudes in adult-onset psychosis.
    Hui CLM; Poon VWY; Ko WT; Miao HY; Chang WC; Lee EHM; Chan SKW; Lin J; Chen EYH
    Schizophr Res; 2016 Jul; 174(1-3):144-149. PubMed ID: 27050476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of favourable outcome in young people with a first episode psychosis without antipsychotic medication.
    Conus P; Cotton SM; Francey SM; O'Donoghue B; Schimmelmann BG; McGorry PD; Lambert M
    Schizophr Res; 2017 Jul; 185():130-136. PubMed ID: 28065484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication-adherent first-episode psychosis patients also relapse: why?
    Levy E; Pawliuk N; Joober R; Abadi S; Malla A
    Can J Psychiatry; 2012 Feb; 57(2):78-84. PubMed ID: 22340147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis.
    Schoeler T; Petros N; Di Forti M; Klamerus E; Foglia E; Murray R; Bhattacharyya S
    Lancet Psychiatry; 2017 Aug; 4(8):627-633. PubMed ID: 28705600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of untreated psychosis: Impact of the definition of treatment onset on its predictive value over three years of treatment.
    Golay P; Alameda L; Baumann P; Elowe J; Progin P; Polari A; Conus P
    J Psychiatr Res; 2016 Jun; 77():15-21. PubMed ID: 26950643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of psychosis remission in psychotic disorders that co-occur with substance use.
    Caton CL; Hasin DS; Shrout PE; Drake RE; Dominguez B; Samet S; Schanzer B
    Schizophr Bull; 2006 Oct; 32(4):618-25. PubMed ID: 16873441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates and predictors of relapse in first-episode non-affective psychosis: a 3-year longitudinal study in a specialized intervention program (PAFIP).
    Pelayo-Terán JM; Gajardo Galán VG; de la Ortiz-García de la Foz V; Martínez-García O; Tabarés-Seisdedos R; Crespo-Facorro B; Ayesa-Arriola R
    Eur Arch Psychiatry Clin Neurosci; 2017 Jun; 267(4):315-323. PubMed ID: 27796500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, predictors, and consequences of long-term refusal of antipsychotic treatment in first-episode psychosis.
    Lambert M; Conus P; Cotton S; Robinson J; McGorry PD; Schimmelmann BG
    J Clin Psychopharmacol; 2010 Oct; 30(5):565-72. PubMed ID: 20814327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reasons for adherence and nonadherence: a pilot study comparing first- and multi-episode schizophrenia patients.
    Sapra M; Weiden PJ; Schooler NR; Sunakawa-McMillan A; Uzenoff S; Burkholder P
    Clin Schizophr Relat Psychoses; 2014 Jan; 7(4):199-206. PubMed ID: 23428784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapse prevention and remission attainment in first-episode non-affective psychosis. A randomized, controlled 1-year follow-up comparison of haloperidol, risperidone and olanzapine.
    Crespo-Facorro B; Pérez-Iglesias R; Mata I; Caseiro O; Martínez-Garcia O; Pardo G; Ramirez-Bonilla M; Pelayo-Terán JM; Vázquez-Barquero JL
    J Psychiatr Res; 2011 Jun; 45(6):763-9. PubMed ID: 21106207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Minor neurological and physical anomalies in patients with first-episode psychosis].
    Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
    Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of substance use on the effectiveness of antipsychotic medication: a prospective, pragmatic study.
    Alisauskiene R; Løberg EM; Gjestad R; Kroken RA; Jørgensen HA; Johnsen E
    Nord J Psychiatry; 2019; 73(4-5):281-287. PubMed ID: 31140342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.